Presentation
10 October 2020 Laser immunotherapy for metastatic pancreatic cancer
Author Affiliations +
Abstract
Pancreatic cancer is an extremely malignant disease with high mortality rate. Currently there is no effective therapeutic strategy for highly metastatic pancreatic cancers. Laser immunotherapy (LIT) is a combination therapeutic approach of targeted phototherapy and immunotherapy, which could destroy treated primary tumors with elimination of untreated metastases. Here, we investigate the antitumor immune response of LIT on a highly aggressive phenotype Pnac02-H7 mouse pancreatic tumor model. LIT affords a remarkable efficacy in suppressing tumor growth in pancreatic tumors in mice, and results in complete tumor regression in many cases. LIT could synergize targeted phototherapy and immunological effects of immunoadjuvant, which represent a promising treatment modality to induce systemic antitumor response through a local intervention, paving the way for the treatment of highly metastatic pancreatic cancers.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Feifan Zhou "Laser immunotherapy for metastatic pancreatic cancer", Proc. SPIE 11553, Optics in Health Care and Biomedical Optics X, 115530Q (10 October 2020); https://doi.org/10.1117/12.2575415
Advertisement
Advertisement
KEYWORDS
Pancreatic cancer

Tumors

Phototherapy

Laser therapeutics

Back to Top